BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31220042)

  • 1. Serum Anti-PGL-1 IgG, IgM, and IgA in a 3-Year Follow-up Study of 4-15-Year-old Leprosy Contacts.
    TiemiNagao-Dias A; Casimiro de Macedo A; Rodrigues RO; Pedroza FHC; Albuquerque AA; Moreira FA; Santos Mateus CD; Tavares CM; Prata de Almeida TL
    Pediatr Infect Dis J; 2019 Sep; 38(9):e193-e198. PubMed ID: 31220042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys?
    de Macedo AC; Guimarães JA; Rodrigues RO; Araújo TDV; Tavares CM; Cabral PB; de Moraes-Pinto MI; Nagao-Dias AT
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28594117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can anti-PGL-I antibody isotypes differentiate leprosy contacts and leprosy patients?
    Albuquerque AA; Dos Santos Mateus C; de Oliveira Rodrigues R; Lima ÉS; Lima LO; da Silva RL; Fernandes MAM; de Macedo AC; Tavares CM; Nogueira PSF; Nagao-Dias AT
    Pathog Glob Health; 2022 Dec; 116(8):477-484. PubMed ID: 34974816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
    Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
    Chujor CS; Bernheimer H; Levis WR; Schwerer B
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil.
    Frota CC; Freitas MV; Foss NT; Lima LN; Rodrigues LC; Barreto ML; Kerr LR
    Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):490-5. PubMed ID: 20447668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies to both M. leprae PGL-I and MMP-II to recognize leprosy patients at an early stage of disease progression.
    Wang H; Liu W; Jin Y; Yu M; Jiang H; Tamura T; Maeda Y; Makino M
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):274-7. PubMed ID: 26320400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis.
    Penna ML; Penna GO; Iglesias PC; Natal S; Rodrigues LC
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004703. PubMed ID: 27192199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
    Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S
    PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of leprosy by examination of household contacts, determination of serum anti-PGL-1 antibodies and consanguinity.
    Bazan-Furini R; Motta AC; Simão JC; Tarquínio DC; Marques W; Barbosa MH; Foss NT
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):536-40. PubMed ID: 21894372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia.
    Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.